Insulin resistance and classic risk factors in type 2 diabetic patients with different subtypes of ischemic stroke

Diabetes Care

Volumn 22, Issue 7, 1999, Pages 1191-1195

  Matsumoto, Kazunari ^a   Miyake, Seibei ^a   Yano, Mayumi ^a   Ueki, Yukitaka ^a   Miyazaki, Atsushi ^a   Hirao, Koichi ^a   Tominaga, Yuko ^a  

^a SASEBO CHUO HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; INSULIN;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BODY MASS; BRAIN INFARCTION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; FEMALE; HUMAN; HYPERINSULINEMIA; HYPERTENSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; MAGNETIC RESONANCE ANGIOGRAPHY; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PULSE PRESSURE; REGRESSION ANALYSIS; RISK FACTOR;

AGE FACTORS; AGED; BODY MASS INDEX; BRAIN ISCHEMIA; CEREBRAL INFARCTION; COGNITION DISORDERS; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPERTENSION; INSULIN RESISTANCE; MAGNETIC RESONANCE ANGIOGRAPHY; MAGNETIC RESONANCE IMAGING; MALE; MEMORY DISORDERS; MIDDLE AGED; REGRESSION ANALYSIS; RISK FACTORS; SMOKING;

EID: 0033017174     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.22.7.1191     Document Type: Article

References (34)

1. Stegmayr B, Asplund K: Diabetes as a risk factor for stroke: a population perspective. Diabetologia 38:1061-1068, 1995
2. Tuomilehto J, Rastenyte D, Jousilahti P, Sarti C, Vartiainen E: Diabetes mellitus as a risk factor for death from stroke: prospective study of the middle-aged Finnish population. Stroke 2:210-215, 1996
3. Currie CJ, Morgan CL, Gill L, Stott NCH, Peters JR: Epidemiology and costs of acute hospital care for cerebrovascular disease in diabetic and nondiabetic populations. Stroke 28:1142-1146, 1997
4. DeFronzo RA, Bonadonna RC, Ferrannini E: Pathogenesis of NIDDM: a balanced overview. Diabetes Care 15:318-368, 1992
5. Reaven GM: Role of insulin resistance in human disease. Diabetes 37:1595-1607, 1988.
6. Kaplan NM: The deadly quartet: upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med 149:1514-1520, 1989
7. DeFronzo RA, Ferrannini E: Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 14:173-194, 1991
8. Shinozaki K, Naritomi H, Shimizu T, Suzuki M, Ikebuchi M, Sawada T, Harano Y: Role of insulin resistance associated with compensatory hyperinsulinemia in ischemic stroke. Stroke 27:37-43, 1996
9. Zunker P, Schick A, Buschmann HC, Georgiadis D, Nabavi DG, Edelmann M, Ringelstein EB: Hyperinsulinism and cerebral microangiopathy. Stroke 27:219-223, 1996
10. Inoue T, Fushimi H, Yamada Y, Udaka F, Kameyama M: Asymptomatic multiple lacunae in diabetics and non-diabetics detected by brain magnetic resonance imaging. Diabetes Res Clin Pract 31:81-86, 1996
11. Yip PK, Jeng JS, Lee TK, Chang YC, Huang ZS, Ng SK, Chen RC: Subtypes of ischemic stroke: a hospital-based stroke registry in Taiwan (SCAN-IV). Stroke 28:2507-2512, 1997
12. Rossetti L, Giaccari A, DeFronzo RA: Glucose toxicity. Diabetes Care 13:610-630, 1990
13. Matsumoto K, Akazawa S, Abiru N, Yano M, Ishibashi M, Uotani S, Matsuo H, Kawasaki E, Yamasaki H, Yamamoto H, Yamaguchi Y, Nagataki S: Insulin response after treatment depends on fasting plasma glucose level in NIDDM. Diabetes Res Clin Pract 26:129-135, 1994
14. Ludvik B, Nolan JJ, Baloga J, Sacks D, Olefsky J: Effect of obesity on insulin resistance in normal subjects and patients with NIDDM. Diabetes 44:1121-1125, 1995
15. Matsumoto K, Miyake S, Yano M, Ueki Y, Yamaguchi Y, Akazawa S, Tominaga Y: Insulin resistance and arteriosclerosis obliterans in patients with NIDDM. Diabetes Care 20:1738-1743, 1997
16. The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus: Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 20:1183-1197, 1997
17. Matsumoto K, Miyake S, Yano M, Ueki Y, Tominaga Y: Increase of lipoprotein (a) with troglitazone. Lancet 350:1748-1749, 1997
18. Bonora E, Moghetti P, Zancanaro C, Cigolini M, Querena M, Cacciatori V, Corgnati A, Muggeo M: Estimates of in vivo insulin action in man: comparison of insulin tolerance tests with euglycemic and hyperglycemic clamp studies. J Clin Endocrinol Metab 68:374-378, 1989
19. Matsumoto K, Yano M, Miyake S, Ueki Y, Yamaguchi Y, Akazawa S, Tominaga Y: Effects of voglibose on glycemic excursions, insulin secretion, and insulin sensitivity in non-insulin-treated NIDDM patients. Diabetes Care 21:256-260, 1998
20. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502, 1972
21. Holme I, Enger SC, Helgeland A, Hjermann I, Leren P, Lund-Larsen PG, Solberg LA, Strong JP: Risk factors and raised atherosclerotic lesions in coronary and cerebral arteries. Atherosclerosis 1:250-256, 1981
22. Lento S, Ronnemaa T, Pyorala K, Laakso M: Predictors of stroke in middle-aged patients with non-insulin-dependent diabetes. Stroke 27:63-68, 1996
23. Inchiostro S, Bertoli G, Zanette G, Donadon V: Evidence of higher insulin resistance in NIDDM patients with ischaemic heart disease. Diabetologia 37:597-603, 1994
24. Bergman RN: Toward physiological understanding of glucose tolerance: minimal model approach. Diabetes 38:1512-1527, 1989
25. Matsumoto K, Yamasaki H, Akazawa S, Sakamaki H, Ishibashi M, Abiru N, Uotani S, Matsuo H, Yamaguchi Y, Tokuyama K, Nagataki S: High-dose but not low-dose dexamethasone impairs glucose tolerance by inducing compensatory failure of pancreatic β-cells in normal men. J Clin Endocrinol Metab 81:2621-2626, 1996
26. Izumino K, Sakamaki H, Ishibashi M, Takino H, Yamasaki H, Yamaguchi Y, Chikuba N, Matsumoto K, Akazawa S, Tokuyama K, Nagataki S: Troglitazone ameliorates insulin resistance in patients with Werner's syndrome. J Clin Endocrinol Metab 82:2391-2395, 1997
27. Sakamaki H, Yamasaki H, Matsumoto K, Izumino K, Kondo H, Sera Y, Ozaki M, Abe T, Kawasaki E, Takino H, Yamaguchi Y, Eguchi K: No deterioration in insulin sensitivity, but impairment of both pancreatic b-cell function and glucose sensitivity in Japanese women with former gestational diabetes mellitus. Diabet Med 15:1039-1044, 1998
28. Sugimori H, Ibayashi S, Irie K, Ooboshi H, Nagao T, Fujii K, Sadoshima S, Fujishima M: Cerebral hemodynamics in hypertensive patients compared with normotensive volunteers: a transcranial Doppler study. Stroke 25:1384-1389, 1994
29. Kinkel WR, Jacobs L, Polachini I, Bates V, Heffner RR: Subcortical arteriosderotic encephalopathy. Arch Neurol 42:951-959, 1985
30. King GL, Goodman AD, Buzney S, Moses A, Kahn CR: Receptors and growth-promoting effects of insulin and insulin-like growth factors on cells from bovine retinal capillaries and aorta. J Clin Invest 75: 1028-1036, 1985
31. Vinters HV, Berliner JA, Beck DW, Maxwell K, Bready JV, Cancilla PA: Insulin stimulates DNA synthesis in cerebral microvessel endothelium and smooth muscle. Diabetes 34:964-969, 1985
32. Kawamori R, Yamasaki Y, Matsushima H, Nishizawa H, Nao K, Hougaku H, Maeda H, Handa N, Matsumoto M, Kamada T: Prevalence of carotid atherosclerosis in diabetic patients: ultrasound high-resolution B-mode imaging on carotid arteries. Diabetes Care 15:1290-1294, 1992
33. Pujia A, Gnasso A, Irace C, Colonna A, Mattioli PL: Common carotid arterial wall thickness in NIDDM subjects. Diabetes Care 17:1330-1336, 1994
34. Kuusisto J, Mykkanen L, Pyorala K, Laakso M: Non-insulin-dependent diabetes and its metabolic control are important predictors of stroke in elderly subjects. Stroke 25: 1157-1164, 1994